Chemotherapy and COVID-19 Outcomes in Patients With Cancer

US cohort study (n=309) reported chemotherapy administration was not associated with severe/critical COVID-19 event (HR, 1.10; 95% CI, 0.73 to 1.60). However, pts with haematological or lung cancers, peri–COVID-19 lymphopenia, or baseline neutropenia had worse COVID-19 outcomes.

Source:

Journal of Clinical Oncology